Correlation Between 23Andme Holding and Intellia Therapeutics
Can any of the company-specific risk be diversified away by investing in both 23Andme Holding and Intellia Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 23Andme Holding and Intellia Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 23Andme Holding Co and Intellia Therapeutics, you can compare the effects of market volatilities on 23Andme Holding and Intellia Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 23Andme Holding with a short position of Intellia Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of 23Andme Holding and Intellia Therapeutics.
Diversification Opportunities for 23Andme Holding and Intellia Therapeutics
0.75 | Correlation Coefficient |
Poor diversification
The 3 months correlation between 23Andme and Intellia is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding 23Andme Holding Co and Intellia Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Intellia Therapeutics and 23Andme Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 23Andme Holding Co are associated (or correlated) with Intellia Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Intellia Therapeutics has no effect on the direction of 23Andme Holding i.e., 23Andme Holding and Intellia Therapeutics go up and down completely randomly.
Pair Corralation between 23Andme Holding and Intellia Therapeutics
Allowing for the 90-day total investment horizon 23Andme Holding Co is expected to under-perform the Intellia Therapeutics. In addition to that, 23Andme Holding is 1.61 times more volatile than Intellia Therapeutics. It trades about -0.08 of its total potential returns per unit of risk. Intellia Therapeutics is currently generating about -0.06 per unit of volatility. If you would invest 4,390 in Intellia Therapeutics on August 27, 2024 and sell it today you would lose (2,960) from holding Intellia Therapeutics or give up 67.43% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
23Andme Holding Co vs. Intellia Therapeutics
Performance |
| Timeline |
| 23Andme Holding |
| Intellia Therapeutics |
23Andme Holding and Intellia Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with 23Andme Holding and Intellia Therapeutics
The main advantage of trading using opposite 23Andme Holding and Intellia Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 23Andme Holding position performs unexpectedly, Intellia Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intellia Therapeutics will offset losses from the drop in Intellia Therapeutics' long position.| 23Andme Holding vs. IDEXX Laboratories | 23Andme Holding vs. Twist Bioscience Corp | 23Andme Holding vs. Guardant Health | 23Andme Holding vs. Agilent Technologies |
| Intellia Therapeutics vs. Editas Medicine | Intellia Therapeutics vs. Caribou Biosciences | Intellia Therapeutics vs. Crispr Therapeutics AG | Intellia Therapeutics vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |